ABOVE: © ISTOCK.COM, NOCTILUXX
Update (June 22, 2022): Reuters reports that despite findings that many of his papers contained falsified or fabricated data, the National Institutes of Health has spent at least $588 million over the past few decades on research based on Anversa’s hypothesis that adult stem cells can heal hearts—an idea that remains unproven in humans. According to the outlet, “The ongoing funding . . . has stoked a significant debate in the stem cell field over whether federal money is being squandered.”
Update (March 15): The Lancet sent The Scientist the retraction notice, which states that the data from Harvard “cannot be held to be reliable.” The editors note that they believe the clinical work conducted in Louisville was done “in good faith.”
Since 2014, a paper in The Lancet describing the results of a clinical trial using supposed cardiac stem cells has sat with an editors’ ...
